Viatris Inc.

Viatris Inc. is a global healthcare company committed to empowering people worldwide to live healthier at every stage of life. Established through the merger of Mylan and Upjohn, Viatris combines a rich heritage of pharmaceutical expertise with a focus on access and sustainability. The company operates in over 165 countries and territories, providing a diverse portfolio of medicines that address various health needs.

Viatris aims to provide high-quality, affordable medicines to patients, ensuring that they have access to essential treatments. The company’s extensive product range includes generic and specialty medications, as well as over-the-counter products. Viatris is dedicated to innovation, investing in research and development to bring new therapies to market.

With a strong commitment to corporate social responsibility, Viatris actively engages in initiatives that promote health equity and improve healthcare systems globally. The company collaborates with healthcare professionals, governments, and non-profit organizations to enhance patient outcomes and support public health initiatives.

Viatris also prioritizes sustainability, focusing on reducing its environmental impact and promoting responsible business practices. The company’s vision is to create a world where everyone has access to the medicines they need, regardless of their circumstances.

Core Values:

• Access: Ensuring that patients can obtain the medications they require.
• Quality: Maintaining the highest standards in manufacturing and product development.
• Innovation: Continuously seeking new solutions to meet evolving health needs.
• Collaboration: Working together with stakeholders to improve health outcomes.

In summary, Viatris Inc. stands as a leader in the pharmaceutical industry, driven by a mission to provide accessible healthcare solutions and improve the quality of life for individuals around the globe.